Webinar—How Decentralized Clinical Trials are Impacting Research

While it’s no secret technology continues to drive disruption and transformation in the clinical trials sector, a new study suggests widespread change may be occurring even faster than we thought. What will the terrain look like in 12 months’ time, and how should sponsors and CROs approach this increasingly patient-centric pathway?

Interpreting the numbers and explaining the significance of these shifts is Dr. Jonathan Cotliar, Chief Medical Officer at Science 37, who painted a vivid picture of the changing landscape and shared his critical insights on how to prepare for the year ahead.

Speakers:

Dr. Jonathan Cotliar, Chief Medical Officer, Science 37

Drew Bustos, Chief Strategy Officer, Science 37

James Chase, Senior Director, Thought Leadership